The recent Azimuth Biotech initiative to expand its operation assets has been described as a ‘partial success’. A primary goal of obtaining sufficient resources to establish a new anti-xeno megaship has been met, Azimuth CEO Torben Rademaker announced. The megaship is expected to be operational within the next few... Read more